These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy. Ganapati R, Pai VV, Banerji U, Thomas J, Saha B. Int J Lepr Other Mycobact Dis; 1997 Dec 17; 65(4):495-7. PubMed ID: 9465161 [No Abstract] [Full Text] [Related]
15. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report. Thomas A, Balakrishnan A, Nagarajan M, Prabhakar R, Tripathy SP, Christian M, Somasundaram PR. Int J Lepr Other Mycobact Dis; 1990 Jun 17; 58(2):273-80. PubMed ID: 2198314 [Abstract] [Full Text] [Related]
16. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases. Shaw IN, Ebenezer G, Rao GS, Natrajan MM, Balasundaram B. Int J Lepr Other Mycobact Dis; 2000 Sep 17; 68(3):272-6. PubMed ID: 11221089 [Abstract] [Full Text] [Related]
17. Diffuse Lepromatous Leprosy Due to Mycobacterium lepromatosis in Quintana Roo, Mexico. Han XY, Quintanilla M. J Clin Microbiol; 2015 Nov 17; 53(11):3695-8. PubMed ID: 26311856 [Abstract] [Full Text] [Related]
18. Primary resistance to single and multiple drugs in leprosy--a mouse footpad study. Shetty VP, Uplekar MW, Antia NH. Lepr Rev; 1996 Dec 17; 67(4):280-6. PubMed ID: 9033198 [Abstract] [Full Text] [Related]
19. Corneal leproma as an initial feature of lepromatous leprosy. Yuen HK, Liu DT, Lam DS. Arch Ophthalmol; 2006 Nov 17; 124(11):1661-2. PubMed ID: 17102021 [No Abstract] [Full Text] [Related]